Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Long-Term Deferred Tax (2016)

IGC Pharma (IGC) has disclosed Long-Term Deferred Tax for 6 consecutive years, with $19000.0 as the latest value for Q4 2016.

  • Quarterly Long-Term Deferred Tax fell 93.76% to $19000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $19000.0 through Dec 2016, down 93.76% year-over-year, with the annual reading at $356684.0 for FY2016, 11.97% up from the prior year.
  • Long-Term Deferred Tax for Q4 2016 was $19000.0 at IGC Pharma, down from $356619.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $356684.0 in Q1 2016, with the low at -$14076.0 in Q1 2012.
  • Average Long-Term Deferred Tax over 5 years is $287677.3, with a median of $318548.0 recorded in 2015.
  • The sharpest move saw Long-Term Deferred Tax skyrocketed 2525.8% in 2013, then tumbled 93.76% in 2016.
  • Over 5 years, Long-Term Deferred Tax stood at -$14076.0 in 2012, then soared by 2221.59% to $298635.0 in 2013, then grew by 6.54% to $318159.0 in 2014, then fell by 4.36% to $304272.0 in 2015, then crashed by 93.76% to $19000.0 in 2016.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $19000.0, $356619.0, and $356334.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.